Author pages are created from data sourced from our academic publisher partnerships and public sources.
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
Summary Background Randomised placebo-controlled trials have shown that daily oral pre-exposure prophylaxis (PrEP) with tenofovir–emtricitabine reduces the risk of HIV infection. However, this… Expand
British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015
Writing Group Duncan Churchill, Chair, Royal Sussex County Hospital, Brighton, UK Laura Waters, Vice Chair, Mortimer Market Centre, London, UK Nadia Ahmed, Mortimer Market Centre, London, UK Brian… Expand
Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study
BackgroundHIV and tuberculosis (TB) are commonly associated. Identifying latent and asymptomatic tuberculosis infection in HIV-positive patients is important in preventing death and morbidity… Expand
CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK
This very large HIV-positive cohort study examines a number of variables that predispose to the development of lymphoma in the HAART era. Despite a declining incidence of lymphoma, the authors define… Expand
Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease?
- J. York, I. Bódi, I. Reeves, P. Riordan-Eva, P. Easterbrook
- The Journal of infection
- 1 August 2005
We report the case of a patient with advanced HIV disease and cryptococcal meningitis, who after an initially good clinical and mycological response to systemic anti-fungal treatment developed… Expand
Changes in the provision of post-exposure prophylaxis for HIV after sexual exposure following introduction of guidelines and publicity campaigns
In July 2004, British Association of Sexual Health and HIV (BASHH) published guidelines for post-exposure prophylaxis following sexual exposure (PEPSE) and the Terence Higgins Trust (THT) launched a… Expand
Experiences of stigma and discrimination in social and healthcare settings among trans people living with HIV in the UK
ABSTRACT The People Living with HIV StigmaSurvey UK 2015 was a community led national survey investigating experiences of people living with HIV in the UK in the past 12 months. Participants aged 18… Expand
Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the “Going Viral” campaign
Routine HIV screening is recommended in those UK hospitals and primary care settings where the HIV prevalence is > 0.2%. For hepatitis B virus (HBV) and hepatitis C virus (HCV), however, testing is… Expand
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis
BackgroundPre-exposure prophylaxis (PrEP) has proven biological efficacy to reduce the sexual acquisition of the human immunodeficiency virus (HIV). The PROUD study found that PrEP conferred higher… Expand
The prevalence of hepatitis B infection in adults with no recognized increased risk of infection.